About Browndove Formulations Private Limited
Data last updated:
Browndove Formulations Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Browndove Healthcare Private Limited. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 10 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33110KA2018PTC114635. Its GSTIN is 33AAHCB9159K1ZA (Tamil Nadu).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹61.56 Lakh. It is led by directors Krishnaswamy Arni Gopalaswamy and Linganna Rajanna.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.24 29th Main Btm Layout 2nd Stage Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.75 Lakh, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹74.14 Lakh and EBITDA of -₹59.2 Lakh (EBITDA margin -401.4%). Revenue has declined at a compounded annual rate (CAGR) of 70% over three years and 18% over five years.
The company is associated with 1 brand: BrownDove. As per MCA filings, the company has open charges of ₹35 Lakh on record.
For more details, the company can be reached via its website browndove.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNo.24 29th Main Btm Layout 2nd Stage Bangalore, Karnataka, India – 560076
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Browndove Formulations Private Limited
The main business activity of Browndove Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Browndove Formulations Private Limited FY 2025 filings available
Browndove Formulations Private Limited reported revenue of ₹14.75 Lakh (down 96% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Browndove Formulations Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 96% fall in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Browndove Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹59.2 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹74.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Browndove Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -401.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Browndove Formulations are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Browndove Formulations Private Limited
Browndove Formulations Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arna Pharma Private Limited | ₹14.9 Lakh (FY 2025) | •••• | •••• | •••• | Visakhapatnam, Andhra Pradesh, India | |
| Svars Medico Private Limited | ₹14.87 Lakh (FY 2025) | •••• | •••• | 550.0% | •••• | Bengaluru, Karnataka, India |
| Taurmed Technologies Private Limited | ₹14.85 Lakh (FY 2023) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Agnivesh Pharmaceuticals Private Limited | ₹14.82 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Noida, Uttar Pradesh, India |
| Onebreath India Private Limited | ₹14.81 Lakh (FY 2021) | •••• | •••• | 83.0% | •••• | Bangalore, Karnataka, India |
| Browndove Formulations Private Limited this company | ₹14.75 Lakh (FY 2024) | •••• | •••• | -96.0% | •••• | Bangalore, Karnataka, India |
| Nivo Healthcare Private Limited | ₹14.74 Lakh (FY 2025) | •••• | •••• | -23.0% | •••• | Pardi, Gujarat, India |
| La Sante Formulations Private Limited | ₹14.69 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Panchkula, Haryana, India |
| Healthtech Medical Devices Pvt Ltd | ₹14.68 Lakh (FY 2023) | •••• | •••• | -83.0% | •••• | Kolkata, West Bengal, India |
| Nakshathra Medi Science Private Limited | ₹14.67 Lakh (FY 2023) | •••• | •••• | -86.0% | •••• | Chennai, Tamil Nadu, India |
| Wehear Hearing Solutions LLP | ₹14.67 Lakh (FY 2021) | •••• | •••• | 1018.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Browndove Formulations by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Browndove Formulations Private Limited
Browndove Formulations Private Limited is audited by AJS And Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AJS And Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Browndove Formulations Private Limited
Browndove Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnaswamy Arni Gopalaswamy Also directs: Wildteal Enterprises LLP, Ibex Engineering Private Limited, HCM Ibex Engineering Private Limited and 1 more | Director | 10 Jul 2018 | 8 Years 3 Months | Current |
| Linganna Rajanna Also directs: Browndove Healthcare Private Limited | Director | 10 Jul 2018 | 8 Years 3 Months | Current |
Ownership and Shareholding of Browndove Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Browndove Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2020 | Karnataka Bank Ltd. | ₹5 Lakh | Open |
| 13 Mar 2019 | Karnataka Bank Ltd. | ₹30 Lakh | Open |
Total charge records: 2 View all charges
MSME Payment Delays by Browndove Formulations Private Limited
Browndove Formulations Private Limited has 18 MSME Form 1 returns on record between 2019 and 2023, listing 146 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Selvamoorthy Poly Pack | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 18 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Browndove Formulations Private Limited
Browndove Formulations operates one associated brand: BrownDove. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Renal care products including dialyzers and catheters are manufactured. | browndove.com |
Employees and EPFO Compliance at Browndove Formulations Private Limited
Employment history and EPFO contributions of people linked to Browndove Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Browndove Formulations Private Limited
Recent Activity on Browndove Formulations Private Limited
Browndove Formulations Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Krishnaswamy Arni Gopalaswamy was appointed as Director on 10 Jul 2018.
Credit Ratings, Litigation & Regulatory Alerts for Browndove Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Browndove Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Browndove Formulations Private Limited
Browndove Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCB9159K1ZA | Tamil Nadu | Active | 06 Sep 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Browndove Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Browndove Formulations Private Limited
Browndove Formulations is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 10 July 2018 (8+ years old) and is registered under CIN U33110KA2018PTC114635.
Browndove Formulations reported revenue of ₹14.75 Lakh for FY 2024 (down 96% YoY).
Browndove Formulations has 2 current directors:
- Krishnaswamy Arni Gopalaswamy - Director
- Linganna Rajanna - Director
Browndove Formulations reported a net loss of ₹74.14 Lakh and EBITDA of -₹59.2 Lakh (EBITDA margin -401.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Browndove Formulations is -70% over three years and -18% over five years. In the latest year (FY 2024) revenue fell 96%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Browndove Formulations is 33AAHCB9159K1ZA, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Browndove Formulations is U33110KA2018PTC114635. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Browndove Formulations was incorporated on 10 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Browndove Formulations by revenue are Arna Pharma Private Limited, Svars Medico Private Limited, Taurmed Technologies Private Limited, Agnivesh Pharmaceuticals Private Limited, Onebreath India Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment).
Krishnaswamy Arni Gopalaswamy was appointed as Director on 10 Jul 2018. Linganna Rajanna was appointed as Director on 10 Jul 2018.
Browndove Formulations has 18 MSME Form 1 returns on record between 2019 and 2023, listing 146 overdue payments to 32 micro and small suppliers. The latest return was filed on 05 Nov 2023.
Browndove Formulations can be reached through the website browndove.com. Its registered office is in Bangalore, Karnataka, India.